Home ETF List About

ETF Holdings Breakdown of EW

Stock NameEdwards Lifesciences Corp
TickerEW(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS28176E1082
LEIYA13X31F3V31L8TMPR58

EW institutional holdings

The following institutional investment holdings of EW have been identified

Date ETF ISIN/Name Num Shares Book value
2025-09-25 IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc)) 1,389,968 0.1%USD 104,622,891 0.9%
2025-09-25 IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist)) 1,389,968 0.1%USD 104,622,891 0.9%
2025-09-25 IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc)) 1,389,968 0.1%USD 104,622,891 0.9%
2025-09-25 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 870,448USD 65,518,621 0.8%
2025-09-25 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 870,448USD 65,518,621 0.8%
2025-09-25 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 870,448USD 65,518,621 0.8%
2025-09-25 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 870,448USD 65,518,621 0.8%
2025-09-25 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 93,849 0.7%USD 7,064,014 1.5%
2025-09-25 IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist)) 209,105 0.0%USD 15,739,333 0.8%
2025-09-25 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 165,666USD 12,469,680 0.8%
2025-09-25 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 165,666USD 12,469,680 0.8%
2025-09-25 IE00BYX2JD69 (iShares MSCI World SRI UCITS ETF) 318,641USD 23,984,108 0.8%
2025-09-25 IE00BMZ17T93 (iShares MSCI World SRI UCITS ETF GBP Hedged (Dist) GBP) 318,641USD 23,984,108 0.8%
2025-09-25 IE00BMZ17X30 (iShares MSCI World SRI UCITS ETF USD Hedged (Dist)) 318,641USD 23,984,108 0.8%
2025-09-25 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 175,722 0.1%USD 13,226,595 0.9%
2025-09-25 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 175,722 0.1%USD 13,226,595 0.9%
2025-09-25 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 175,722 0.1%USD 13,226,595 0.9%
2025-09-25 IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc)) 155,540 200.0%USD 11,707,496 199.2%
2025-09-25 IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist)) 155,540 200.0%USD 11,707,496 199.2%
2025-09-25 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 64,357USD 4,844,151 0.8%
2025-09-25 IE00BYVJRR92 (iShares MSCI USA SRI UCITS ETF USD (Acc)) 168,986USD 12,719,576 0.8%
2025-09-25 IE00BZ173V67 (iShares MSCI USA SRI UCITS ETF EUR Hedged (Dist)) 168,986USD 12,719,576 0.8%
2025-09-25 IE00BZ173T46 (iShares MSCI USA SRI UCITS ETF USD (Dist)) 168,986USD 12,719,576 0.8%
2025-09-25 IE00BMWPV470 (iShares MSCI USA SRI UCITS ETF GBP Hedged (Dist)) 168,986USD 12,719,576 0.8%
2025-09-25 IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc)) 91,781USD 5,916,461 1.4%
2025-09-25 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 111,488USD 8,391,702 0.8%
2025-09-25 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 111,488USD 8,391,702 0.8%
2025-09-25 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 43,964USD 3,309,170 0.8%
2025-09-25 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 43,964USD 3,309,170 0.8%
2025-09-25 IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)) 115,794 0.8%USD 8,715,814 1.6%
2025-09-25 IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc)) 115,794 0.8%USD 8,715,814 1.6%
2025-09-25 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 38,236USD 2,464,800 1.4%
2025-09-25 IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc)) 278,665USD 20,975,115 0.8%
2025-09-25 IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF) 278,665USD 20,975,115 0.8%
2025-09-25 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 25,064USD 1,886,567 0.8%
2025-09-25 IE00B6SPMN59 (iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Acc)) 14,534 0.1%USD 1,093,974 1.0%
2025-09-25 IE00BD93YH54 (iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Dist)) 14,534 0.1%USD 1,093,974 1.0%
2025-09-25 IE00B57X3V84 (iShares Dow Jones Global Sustainability Screened UCITS ETF USD (Acc)) 50,221USD 3,780,135 0.8%
2025-09-25 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 12,900USD 970,983 0.8%
2025-09-25 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 198,446USD 14,937,030 0.8%
2025-09-25 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 103,330USD 7,777,649 0.8%
2025-09-25 IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc)) 103,330USD 7,777,649 0.8%
2025-09-25 IE00BMXC7V63 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD (Acc)) 13,589USD 1,022,844 0.8%
2025-09-25 IE000G4PH2B1 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD Dist) 13,589USD 1,022,844 0.8%
2025-09-25 IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc)) 14,619USD 824,341 1.6%
2025-09-25 IE000R9FA4A0 (iShares S&P 500 ESG UCITS ETF USD (Acc)) 11,037USD 830,755 0.8%
2025-09-25 IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist)) 9,185USD 691,355 0.8%
2025-09-25 IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc)) 9,185USD 691,355 0.8%
2025-09-25 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 3,820USD 215,404 1.6%
2025-09-25 IE00BMX0DF60 (iShares US Medical Devices UCITS ETF) 83,010 6.1%USD 6,248,163 6.9%
2025-09-25 IE00013A2XD6 (iShares MSCI ACWI SRI UCITS ETF USD(Dist)) 3,347USD 251,929 0.8%
Total =12,734,031 USD 956,737,234
Book value of shares is calculated on the adjusted close price of each day (row).

News associated with EW

Edwards Lifesciences (NYSE:EW) Cut to Buy at Wall Street Zen
Edwards Lifesciences (NYSE:EW – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday. A number of other research analysts have also issued reports on the company. Wells Fargo & Company boosted their price objective on Edwards Lifesciences […] - 2025-09-15 05:40:50
Atria Wealth Solutions Inc. Sells 29,763 Shares of Edwards Lifesciences Corporation (NYSE:EW)
Atria Wealth Solutions Inc. cut its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 81.7% during the 1st quarter, HoldingsChannel reports. The firm owned 6,662 shares of the medical research company’s stock after selling 29,763 shares during the period. Atria Wealth Solutions Inc.’s holdings in Edwards Lifesciences were worth $483,000 as […] - 2025-08-14 05:04:55
Edwards Lifesciences (NYSE:EW) Raised to Buy at BTIG Research
Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by investment analysts at BTIG Research from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Marketbeat reports. The firm currently has a $100.00 target price on the medical research company’s stock. BTIG Research’s price target points to a potential […] - 2025-07-31 03:02:52
Edwards Lifesciences (NYSE:EW) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday. Several other research analysts have also weighed in on EW. Wells Fargo & Company lifted their price objective on Edwards Lifesciences from $80.00 to $84.00 and […] - 2025-07-29 02:58:49
Edwards Lifesciences (NYSE:EW) Price Target Raised to $82.00
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective upped by Truist Financial from $81.00 to $82.00 in a research note published on Friday,Benzinga reports. They currently have a hold rating on the medical research company’s stock. A number of other research firms have also weighed in on EW. Wall Street Zen lowered shares […] - 2025-07-28 04:08:50
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its price target increased by JPMorgan Chase & Co. from $80.00 to $85.00 in a report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other brokerages also recently issued reports on EW. Wells Fargo & […] - 2025-07-28 04:08:48
Edwards Lifesciences (NYSE:EW) Price Target Raised to $95.00
Edwards Lifesciences (NYSE:EW – Free Report) had its price target raised by Barclays from $90.00 to $95.00 in a report published on Friday,Benzinga reports. Barclays currently has an overweight rating on the medical research company’s stock. A number of other equities analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft lifted their price […] - 2025-07-28 02:46:53
Stifel Nicolaus Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price
Edwards Lifesciences (NYSE:EW – Free Report) had its target price upped by Stifel Nicolaus from $90.00 to $95.00 in a research report sent to investors on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. EW has been the topic of several other research reports. Evercore ISI increased […] - 2025-07-28 02:46:53
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Robert W. Baird Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its target price boosted by Robert W. Baird from $78.00 to $79.00 in a research report report published on Friday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Other research analysts have also issued reports about the stock. Evercore ISI […] - 2025-07-28 02:46:51
Edwards Lifesciences (NYSE:EW) Price Target Raised to $80.00
Edwards Lifesciences (NYSE:EW – Free Report) had its target price lifted by Evercore ISI from $77.00 to $80.00 in a research report report published on Friday,Benzinga reports. The firm currently has an in-line rating on the medical research company’s stock. A number of other brokerages have also issued reports on EW. Argus upgraded shares of […] - 2025-07-28 02:46:51
Deutsche Bank Aktiengesellschaft Issues Positive Forecast for Edwards Lifesciences (NYSE:EW) Stock Price
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $85.00 to $94.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a buy rating on the medical research company’s stock. Several other equities analysts have also issued reports on EW. Dbs Bank upgraded […] - 2025-07-28 02:46:49
Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Edwards Lifesciences (NYSE:EW – Free Report) had its price objective lifted by Wells Fargo & Company from $80.00 to $84.00 in a report released on Friday morning,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. A number of other research analysts also recently commented on EW. Dbs Bank raised shares […] - 2025-07-28 02:46:49
J.W. Cole Advisors Inc. Has $814,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW)
J.W. Cole Advisors Inc. raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 220.2% in the 1st quarter, HoldingsChannel reports. The fund owned 11,224 shares of the medical research company’s stock after acquiring an additional 7,719 shares during the period. J.W. Cole Advisors Inc.’s holdings in Edwards Lifesciences were worth $814,000 at […] - 2025-07-25 05:12:50
Sigma Planning Corp Has $294,000 Position in Edwards Lifesciences Corporation (NYSE:EW)
Sigma Planning Corp boosted its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 4.9% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,055 shares of the medical research company’s stock after acquiring an additional 191 shares during the quarter. Sigma Planning Corp’s holdings in Edwards Lifesciences were worth $294,000 as of its […] - 2025-07-21 05:06:55
Edwards Lifesciences Corporation (NYSE:EW) Position Lowered by Ballentine Partners LLC
Ballentine Partners LLC decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,109 shares of the medical research company’s stock after selling 375 shares during the period. Ballentine Partners LLC’s holdings […] - 2025-07-16 06:51:32
Alps Advisors Inc. Purchases Shares of 5,090 Edwards Lifesciences Corporation (NYSE:EW)
Alps Advisors Inc. bought a new position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) during the 1st quarter, HoldingsChannel reports. The fund bought 5,090 shares of the medical research company’s stock, valued at approximately $369,000. A number of other hedge funds have also recently added to or reduced their stakes in the stock. Norges […] - 2025-07-16 06:01:07
Allworth Financial LP Has $264,000 Stock Holdings in Edwards Lifesciences Corporation (NYSE:EW)
Allworth Financial LP raised its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.3% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,513 shares of the medical research company’s stock after purchasing an additional 208 shares during the quarter. Allworth […] - 2025-07-16 06:01:06
IHI, IDXX, BDX, EW: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares U.S. Medical Devices ETF (Symbol: IHI) where we have detected an approximate $100.6 million dollar outflow -- that's a 2.2% decrease week ov - 2025-07-14 11:51:23
Stratos Wealth Partners LTD. Sells 929 Shares of Edwards Lifesciences Corporation (NYSE:EW)
Stratos Wealth Partners LTD. cut its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.6% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 13,254 shares of the medical research company’s stock after selling 929 shares during the quarter. Stratos Wealth Partners LTD.’s […] - 2025-07-13 05:26:55
D.A. Davidson & CO. Has $675,000 Stake in Edwards Lifesciences Corporation (NYSE:EW)
D.A. Davidson & CO. decreased its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 7.2% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 9,313 shares of the medical research company’s stock after selling 720 shares during the period. D.A. Davidson […] - 2025-07-10 06:03:09
Mutual Advisors LLC Has $266,000 Stock Position in Edwards Lifesciences Corporation (NYSE:EW)
Mutual Advisors LLC decreased its stake in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 5.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,498 shares of the medical research company’s stock after selling 218 shares during the period. […] - 2025-07-09 05:42:59
Edwards Lifesciences Corporation (NYSE:EW) Shares Acquired by Mirae Asset Global Investments Co. Ltd.
Mirae Asset Global Investments Co. Ltd. grew its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 15.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 68,013 shares of the medical research company’s stock after buying an additional 8,915 shares during […] - 2025-07-02 05:34:52
Perigon Wealth Management LLC Acquires 278 Shares of Edwards Lifesciences Corporation (NYSE:EW)
Perigon Wealth Management LLC lifted its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 6.9% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 4,325 shares of the medical research company’s stock after buying an additional 278 shares during the period. Perigon Wealth Management LLC’s holdings in Edwards Lifesciences were […] - 2025-07-01 05:14:56
Envestnet Portfolio Solutions Inc. Sells 30,681 Shares of Edwards Lifesciences Corporation (NYSE:EW)
Envestnet Portfolio Solutions Inc. lessened its holdings in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 90.7% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,147 shares of the medical research company’s stock after selling 30,681 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings […] - 2025-07-01 04:42:50
Sequoia Financial Advisors LLC Purchases 15,417 Shares of Edwards Lifesciences Corporation (NYSE:EW)
Sequoia Financial Advisors LLC increased its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 190.9% in the first quarter, Holdings Channel reports. The institutional investor owned 23,495 shares of the medical research company’s stock after buying an additional 15,417 shares during the period. Sequoia Financial Advisors LLC’s holdings in Edwards Lifesciences […] - 2025-06-30 05:34:56
Edwards Lifesciences Corporation (NYSE:EW) Shares Sold by Bessemer Group Inc.
Bessemer Group Inc. trimmed its stake in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 47.8% during the 1st quarter, Holdings Channel reports. The fund owned 17,101 shares of the medical research company’s stock after selling 15,654 shares during the quarter. Bessemer Group Inc.’s holdings in Edwards Lifesciences were worth $1,240,000 as of […] - 2025-06-30 04:38:49
Flagship Harbor Advisors LLC Reduces Holdings in Edwards Lifesciences Corporation (NYSE:EW)
Flagship Harbor Advisors LLC decreased its position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 2.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,906 shares of the medical research company’s stock after selling 307 shares during the period. Flagship […] - 2025-06-25 06:30:56
Janney Montgomery Scott LLC Has $3.11 Million Holdings in Edwards Lifesciences Corporation (NYSE:EW)
Janney Montgomery Scott LLC trimmed its stake in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 0.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 42,861 shares of the medical research company’s stock after selling 234 shares during the period. Janney Montgomery […] - 2025-06-25 05:01:00
Kentucky Retirement Systems Insurance Trust Fund Purchases 13,142 Shares of Edwards Lifesciences Corporation (NYSE:EW)
Kentucky Retirement Systems Insurance Trust Fund raised its position in Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 339.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,016 shares of the medical research company’s stock after purchasing an additional 13,142 shares during the […] - 2025-06-24 05:20:56
Edwards Lifesciences Corporation (NYSE:EW) Shares Bought by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC grew its holdings in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) by 66.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 21,095 shares of the medical research company’s stock after purchasing an additional 8,453 […] - 2025-06-19 05:22:53

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.